文献速递胃肠外科

经肛入路全直肠系膜切除术治疗直肠癌的长期结局

Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
PubMed 文献 · Surg Endosc · 2017-06-22

该研究基于前瞻性维护的直肠癌数据库,纳入373例连续接受经肛联合腹部入路行保肛TME手术的直肠癌患者,分析围术期、病理及肿瘤学结局。中位随访5.5年,96%的TME标本完整或近完整,94%环周切缘阴性,98.6%远端切缘阴性;局部复发率7.4%,远处转移率19.5%,Kaplan-Meier 5年生存率90%。结论认为该技术可获得充分的远端及环周切缘、高质量TME标本、低局部复发风险及优异的总体生存。

要点

  • 经肛入路TME可获得96%完整/近完整标本和94%环周切缘阴性。
  • 5年局部复发率7.4%,远处转移率19.5%,5年生存率90%。
  • 围术期并发症率13.4%,死亡率0.3%,支持该技术在直肠癌中的应用。

核心结论

  • 经肛入路TME治疗直肠癌可获得充分的远端及环周切缘、高质量TME标本、低局部复发风险和优异的总体生存。

研究设计与样本

  • 回顾性分析前瞻性维护的直肠癌数据库,纳入373例连续接受经肛联合腹部入路行保肛TME手术的直肠癌患者。

主要发现

  • 91%的肿瘤位于直肠远端,53.2%在就诊时肿瘤固定或粘连。
  • 97.7%接受新辅助放疗(平均5405 cGy,以5-氟尿嘧啶为基础),新辅助治疗结束至手术平均11周。
  • 180例和193例分别通过开腹和腹腔镜完成腹部手术部分。
  • 96%的TME标本完整或近完整,94%环周切缘阴性,98.6%远端切缘阴性。
  • 围术期并发症率和死亡率分别为13.4%和0.3%;局部复发率7.4%,远处转移率19.5%,Kaplan-Meier 5年生存率90%。

临床怎么用

  • 对于远端直肠癌,经肛入路TME可作为一种保肛手术选择,有助于实现高质量TME和切缘阴性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The challenge of performing a good total mesorectal excision (TME) dissection, particularly in the distal 1/3 of the rectum, has spurred interest in new techniques. Robotic surgery is advocated by some, and more recently, a "new" approach, the transanal total mesorectal excision, has been popularized to address this problem. While great interest in this technique exists, little long-term outcome data are available. We have been utilizing a transanal abdominal transanal approach to TME in order to facilitate the distal dissection, and here, we provide our long-term outcomes using this approach in the management of rectal cancer. METHODS: From a prospectively maintained rectal cancer database, we identified 373 consecutive rectal cancers treated with sphincter preservation surgery through a combined transanal and abdominal approach to TME. Perioperative, pathological, and oncologic outcomes were analyzed. RESULTS: Three hundred and seventy-three patients with rectal cancer underwent a transanally initiated TME with mean follow-up of 5.5 years. 91% of cancers were in the distal rectum. 68.9% were men and 53.2% of cancers were tethered or fixed on presentation. 97.7% received neoadjuvant radiotherapy (mean 5405 cGy, 5-fluorouracil based); average time from completion of neoadjuvant therapy to surgery was 11 weeks. 180 and 193 patients underwent completion of their operation through open and laparoscopic abdominal approaches. 96% of TME specimens were complete/near complete, 94% had a negative circumferential resection margin, and 98.6% had a negative distal margin. Perioperative morbidity and mortality rates were 13.4 and 0.3%. Overall local recurrence (LR), DM, and Kaplan-Meier 5-year actuarial survival were 7.4, 19.5, and 90%, respectively. CONCLUSION: This is the first report of long-term data using a transanal approach to TME supporting this approach for rectal cancer. Our data with 5-year follow-up show that adequate distal and circumferential margins with very good-quality TME specimens, and a low risk for LR with excellent overall survival can be achieved using this technique. Our long-term results support the promising reports of early experiences in the literature.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Marks JH, Myers EA, Zeger EL, et al. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Surg Endosc. 2017. PMID: 28643051. doi:10.1007/s00464-017-5597-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。